BusinessTesaro Announces Presentations of Abstracts at the 2017 American Society of Clinical Oncology (ASCO) Annual MeetingBy Nasdaq OMXMay 25, 2017, 8:19 PM UTC
BusinessTESARO Announces Availability of Zejula™ (Niraparib) for Patients With Recurrent Ovarian Cancer in the U.S.By Nasdaq OMXApr 19, 2017, 8:16 PM UTC
BusinessTESARO Announces Availability of Zejula™ (Niraparib) for Patients With Recurrent Ovarian Cancer in the U.S.By Nasdaq OMXApr 19, 2017, 8:16 PM UTC
BusinessTesaro Wins Awards for Clinical Development Team of the Year and Clinical Partnership of the YearBy Nasdaq OMXApr 7, 2017, 12:30 PM UTC
